1/1
2 files

SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice

dataset
posted on 15.09.2020, 15:41 by John Wilding, Kevin Fernando, Nicola Milne, Marc Evans, Amar Ali, Steve Bain, June James, Philip Newland-Jones, Dipesh Patel, Adie Viljoen

The above summary slide and prescribing tool represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

Exports